Evidence map›Paper›PMID 35115366›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2022

Paolo Zanotti-Fregonara, Tatsuya Ishiguro, Kosuke Yoshihara, Shiro Ishii, Takayuki Enomoto

Open access · bronzeAbstract read
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Paolo Zanotti-FregonaraMolecular Imaging Branch, National Institute of Mental Health, Bethesda, Maryland; zanottifregonp@nih.gov.
Tatsuya IshiguroDepartment of Obstetrics and Gynecology, Niigata University Medical & Dental Hospital, Niigata, Japan; and.
Kosuke YoshiharaDepartment of Obstetrics and Gynecology, Niigata University Medical & Dental Hospital, Niigata, Japan; and.
Shiro IshiiDepartment of Radiology and Nuclear Medicine, Fukushima Medical University Hospital, Fukushima, Japan.
Takayuki EnomotoDepartment of Obstetrics and Gynecology, Niigata University Medical & Dental Hospital, Niigata, Japan; and.
Niigata University Medical and Dental Hospital · JPFukushima Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The fetal absorbed dose from

Indexed as

Fluorodeoxyglucose F18NeoplasmsFemaleFetusHumansMagnetic Resonance ImagingPositron Emission Tomography Computed TomographyPregnancyRadiation DosageRadiopharmaceuticalsRetrospective StudiesFluorodeoxyglucose F18Radiopharmaceuticals18F-FDGfetal dosimetryPET/MRIpregnancy

Identifiers

PMID35115366
PMCPMC9536700
OpenAlexW4210622874

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.